Mode
Text Size
Log in / Sign up

Fungal infection

Subtypes of Fungal infection

Coccidioidomycosis 6 Blastomycosis 3 Histoplasmosis 3 Mucormycosis 3 Invasive candidiasis 2 Valley Fever 2 Aspergillosis 1 Mucorales infection 1 Mycetoma 1 Vulvovaginal candidiasis 1

24 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Fungal infection

29 trials tracked for Fungal infection: 16 in phase 3 or 4 and 5 with published results. The most-cited published study has 273 citations.

29Trials tracked
16Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 4 Phase 3 12 Phase 2 4 Phase 1 6 Other / NA 3
  1. Phase 3 A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) Completed · 273 cited
  2. Phase 3 Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Completed · 108 cited
  3. Phase 3 Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole Completed · 39 cited
  4. Phase 3 Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Completed · 39 cited
  5. Phase 3 Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis Completed · 16 cited
  6. Phase 4 A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing Completed
Show 23 more trials
  1. Phase 4 Itraconazole Oral Absorption Completed
  2. Phase 4 Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) Completed
  3. Phase 4 Effect of Weight and/or Obesity on Caspofungin Drug Concentrations Completed
  4. Phase 3 Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Completed
  5. Phase 3 Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi Completed
  6. Phase 3 A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) Completed
  7. Phase 3 Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551) Completed
  8. Phase 3 Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis Completed
  9. Phase 3 Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) Completed
  10. Phase 3 A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) Completed
  11. Phase 2 Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients Completed
  12. Phase 2 CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension Completed
  13. Phase 2 Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia Completed
  14. Phase 2 Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options Completed
  15. Phase 1 Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615) Completed
  16. Phase 1 Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) Completed
  17. Phase 1 Anidulafungin PK in Infants and Toddlers Completed
  18. Phase 1 Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120) Completed
  19. Phase 1 Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers Completed
  20. Phase 1 Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) Completed
  21. N/A A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation Completed
  22. N/A Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection Completed
  23. N/A Vfend Special Investigation For Prophylaxis Completed

Showing the 29 most-cited and recently-updated of 29 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Fungal infection

Does having a fungal infection mean I have a bacterial infection in my lungs?

Having a fungal infection in your lungs does not automatically mean you have a bacterial infection, though both can occur together in certain conditions like HIV or COPD.

Full answer →